Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Viper Energy
VNOM
$8.71B
| $20.3M | ﹤0.01% |
+527,129
| New | +$17.8M |
|
1602
NBT Bancorp
NBTB
$2.74B
| $20.3M | ﹤0.01% |
552,705
+22,496
| +4% | +$814K |
|
1603
Supernus Pharmaceuticals
SUPN
$2.59B
| $20.2M | ﹤0.01% |
592,646
+36,716
| +7% | +$1.09M |
|
1604
Quanex
NX
$819M
| $20.2M | ﹤0.01% |
525,645
+16,064
| +3% | +$536K |
|
|
MFA
1605
MFA Financial
MFA
$926M
| $20.2M | ﹤0.01% |
1,769,095
+39,408
| +2% | +$442K |
|
1606
Green Plains
GPRE
$1.18B
| $20.1M | ﹤0.01% |
868,669
+79,947
| +10% | +$1.75M |
|
1607
Encore Capital Group
ECPG
$2.02B
| $20.1M | ﹤0.01% |
439,820
+27,722
| +7% | +$1.37M |
|
|
DEA
1608
Easterly Government Properties
DEA
$1.13B
| $20.1M | ﹤0.01% |
696,885
+35,701
| +5% | +$1.08M |
|
1609
Intellia Therapeutics
NTLA
$1.49B
| $20M | ﹤0.01% |
728,295
+28,067
| +4% | +$780K |
|
1610
Horace Mann Educators
HMN
$2.1B
| $20M | ﹤0.01% |
539,886
+16,318
| +3% | +$579K |
|
1611
Check Point Software Technologies
CHKP
$13B
| $20M | ﹤0.01% |
121,685
-20,114
| -14% | -$3.22M |
|
1612
Howard Hughes
HHH
$3.81B
| $20M | ﹤0.01% |
288,282
+12,367
| +4% | +$918K |
|
1613
StepStone Group
STEP
$3.61B
| $19.9M | ﹤0.01% |
557,823
-5,783
| -1% | -$196K |
|
|
CSGS
1614
DELISTED
CSG Systems International
CSGS
| $19.9M | ﹤0.01% |
386,101
+11,884
| +3% | +$618K |
|
1615
ACV Auctions
ACVA
$1.31B
| $19.9M | ﹤0.01% |
1,059,907
+15,492
| +1% | +$243K |
|
|
PRFT
1616
DELISTED
Perficient Inc
PRFT
| $19.9M | ﹤0.01% |
353,109
+10,789
| +3% | +$706K |
|
1617
Enterprise Products Partners
EPD
$82.3B
| $19.8M | ﹤0.01% |
720,728
-8,579
| -1% | -$236K |
|
1618
C3.ai
AI
$1.43B
| $19.8M | ﹤0.01% |
730,881
+24,204
| +3% | +$680K |
|
|
NARI
1619
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $19.8M | ﹤0.01% |
412,219
+6,186
| +2% | +$330K |
|
1620
Brookdale Senior Living
BKD
$3.49B
| $19.8M | ﹤0.01% |
2,991,826
-221,532
| -7% | -$1.29M |
|
|
CWEN.A
1621
DELISTED
Clearway Energy Class A
CWEN.A
| $19.7M | ﹤0.01% |
917,256
+250,275
| +38% | +$5.48M |
|
1622
Surgery Partners
SGRY
$2.01B
| $19.6M | ﹤0.01% |
657,793
+47,919
| +8% | +$1.5M |
|
1623
PENN Entertainment
PENN
$2.75B
| $19.6M | ﹤0.01% |
1,077,253
+59,472
| +6% | +$1.23M |
|
|
ACLX
1624
DELISTED
Arcellx
ACLX
| $19.6M | ﹤0.01% |
282,010
+17,832
| +7% | +$1.13M |
|
1625
SiriusXM
SIRI
$9.98B
| $19.6M | ﹤0.01% |
504,813
+9,017
| +2% | +$429K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.